跳至主要内容
临床试验/EUCTR2005-000778-31-AT
EUCTR2005-000778-31-AT进行中(未招募)不适用

OMEGA-3-POLYUNSATURATED FATTY-ACIDS (n3-PUFA) IN PATIENTS WITH SEVERE CHRONIC HEART FAILURE: EFFECTS ON ENDOTHELIAL FUNCTION, LEFT VENTRICULAR REMODELLING, NATRIURETIC PEPTIDE LEVELS, AND EXERCISE CAPACITY

Dept. of Cardiology, Medical University of Vienna0 个研究点目标入组 145 人开始时间: 2005年4月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
145

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • chronic heart failure of non-ischemic origin
  • Age =18 years
  • NYHA functional class III-IV
  • LVEF < 35 %
  • Optimized heart failure therapy according to the ESC guidelines
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Current therapy with omacor or other fish oil products
  • Known hypersensitivity to the study drug
  • Ischemic cardiomyopathy
  • Uncorrected significant valvular heart disase
  • Heart failure due to congenital heart disease
  • Restrictive cardiomyopathy
  • Alcoholic heart disease
  • Acute myocarditis
  • continuous i.v. therapy for heart failure
  • mechanical assist device
  • Life expectancy <1 year due to non-cardiac causes
  • Inability to perform bicycle testing
  • Women of childbearing potential who do not practice a save contraception method
  • Current participation in another intervention study.
  • Previous participation in another study with an intervention within the last 3 months.

研究者

发起方
Dept. of Cardiology, Medical University of Vienna

相似试验